Both in Pharmaceuticals
USANA Health Sciences vs Rocket Pharmaceuticals
Over the past year USNA returned −26.9% and RCKT returned −32.8%; their daily moves had a correlation of 0.07.
USNA −26.9% RCKT −32.8%Growth of $1, one year, split-adjusted
| Metric | USNA | RCKT |
|---|---|---|
| Price | $14.34 | $2.54 |
| Market cap | $265.0M | $278.8M |
| Today | −1.92% | −1.55% |
| 1 month | −0.9% | −3.4% |
| 6 months | −24.7% | −27.0% |
| Year to date | −26.9% | −27.6% |
| 1 year | −29.5% | −36.0% |
| Revenue growth (YoY) | −5.3% | — |
| Gross margin | 78.3% | — |
| Net margin | −9.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | $168.6M | $262.5M |
| Dividend yield | — | — |
| Volatility (60d) | 38.5% | 66.1% |
| Short % of float | 7.2% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).